Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle: Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes

Elisheva Smith, Rebecca A. Redman, Christopher R. Logg, Gerhard A. Coetzee, Noriyuki Kasahara, Baruch Frenkel

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Unique cell cycle control is instituted in confluent osteoblast cultures, driving growth to high density. The postconfluent dividing cells share features with cells that normally exit the cell cycle; p27(kip1) is increased, p21(waf1/cip1) is decreased, free E2F DNA binding activity is reduced, and E2F4 is primarily nuclear. E2F4-p130 becomes the predominant E2F-pocket complex formed on E2F sites, but, unlike the complex that typifies resting cells, cyclin A and CDK2 are also present. Administration of dexamethasone at this, but not earlier stages, results in reduction of cyclin A and CDK2 levels with a parallel decrease in the associated kinase activity, dissociation of cyclin A-CDK2 from the E2F4-p130 complexes, and inhibition of G1/S transition. The glucocorticoid-mediated cell cycle attenuation is also accompanied by, but not attributable to, increased p27(kip1) and decreased p21(waf1/cip1) levels. The attenuation of osteoblast growth to high density by dexamethasone is associated with severe impairment of mineralized extracellular matrix formation, unless treatment commences in cultures that have already grown to high density. Both the antimitotic and the antiphenotypic effects are reversible, and both are antagonized by RU486. Thus, glucocorticoids induce premature attenuation of the osteoblast cell cycle, possibly contributing to the osteoporosis induced by these drugs in vivo.

Original languageEnglish (US)
Pages (from-to)19992-20001
Number of pages10
JournalJournal of Biological Chemistry
Volume275
Issue number26
DOIs
StatePublished - Jun 30 2000
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinase 2
Cyclin A
Osteoblasts
Glucocorticoids
Cell Cycle
Cells
Dexamethasone
Antimitotic Agents
Growth
Cell Cycle Checkpoints
Osteoporosis
Extracellular Matrix
Phosphotransferases
Cell culture
DNA
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry

Cite this

Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle : Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. / Smith, Elisheva; Redman, Rebecca A.; Logg, Christopher R.; Coetzee, Gerhard A.; Kasahara, Noriyuki; Frenkel, Baruch.

In: Journal of Biological Chemistry, Vol. 275, No. 26, 30.06.2000, p. 19992-20001.

Research output: Contribution to journalArticle

Smith, Elisheva ; Redman, Rebecca A. ; Logg, Christopher R. ; Coetzee, Gerhard A. ; Kasahara, Noriyuki ; Frenkel, Baruch. / Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle : Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 26. pp. 19992-20001.
@article{bf905089f47c4d1c917d019c3595c9f0,
title = "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle: Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes",
abstract = "Unique cell cycle control is instituted in confluent osteoblast cultures, driving growth to high density. The postconfluent dividing cells share features with cells that normally exit the cell cycle; p27(kip1) is increased, p21(waf1/cip1) is decreased, free E2F DNA binding activity is reduced, and E2F4 is primarily nuclear. E2F4-p130 becomes the predominant E2F-pocket complex formed on E2F sites, but, unlike the complex that typifies resting cells, cyclin A and CDK2 are also present. Administration of dexamethasone at this, but not earlier stages, results in reduction of cyclin A and CDK2 levels with a parallel decrease in the associated kinase activity, dissociation of cyclin A-CDK2 from the E2F4-p130 complexes, and inhibition of G1/S transition. The glucocorticoid-mediated cell cycle attenuation is also accompanied by, but not attributable to, increased p27(kip1) and decreased p21(waf1/cip1) levels. The attenuation of osteoblast growth to high density by dexamethasone is associated with severe impairment of mineralized extracellular matrix formation, unless treatment commences in cultures that have already grown to high density. Both the antimitotic and the antiphenotypic effects are reversible, and both are antagonized by RU486. Thus, glucocorticoids induce premature attenuation of the osteoblast cell cycle, possibly contributing to the osteoporosis induced by these drugs in vivo.",
author = "Elisheva Smith and Redman, {Rebecca A.} and Logg, {Christopher R.} and Coetzee, {Gerhard A.} and Noriyuki Kasahara and Baruch Frenkel",
year = "2000",
month = "6",
day = "30",
doi = "10.1074/jbc.M001758200",
language = "English (US)",
volume = "275",
pages = "19992--20001",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "26",

}

TY - JOUR

T1 - Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle

T2 - Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes

AU - Smith, Elisheva

AU - Redman, Rebecca A.

AU - Logg, Christopher R.

AU - Coetzee, Gerhard A.

AU - Kasahara, Noriyuki

AU - Frenkel, Baruch

PY - 2000/6/30

Y1 - 2000/6/30

N2 - Unique cell cycle control is instituted in confluent osteoblast cultures, driving growth to high density. The postconfluent dividing cells share features with cells that normally exit the cell cycle; p27(kip1) is increased, p21(waf1/cip1) is decreased, free E2F DNA binding activity is reduced, and E2F4 is primarily nuclear. E2F4-p130 becomes the predominant E2F-pocket complex formed on E2F sites, but, unlike the complex that typifies resting cells, cyclin A and CDK2 are also present. Administration of dexamethasone at this, but not earlier stages, results in reduction of cyclin A and CDK2 levels with a parallel decrease in the associated kinase activity, dissociation of cyclin A-CDK2 from the E2F4-p130 complexes, and inhibition of G1/S transition. The glucocorticoid-mediated cell cycle attenuation is also accompanied by, but not attributable to, increased p27(kip1) and decreased p21(waf1/cip1) levels. The attenuation of osteoblast growth to high density by dexamethasone is associated with severe impairment of mineralized extracellular matrix formation, unless treatment commences in cultures that have already grown to high density. Both the antimitotic and the antiphenotypic effects are reversible, and both are antagonized by RU486. Thus, glucocorticoids induce premature attenuation of the osteoblast cell cycle, possibly contributing to the osteoporosis induced by these drugs in vivo.

AB - Unique cell cycle control is instituted in confluent osteoblast cultures, driving growth to high density. The postconfluent dividing cells share features with cells that normally exit the cell cycle; p27(kip1) is increased, p21(waf1/cip1) is decreased, free E2F DNA binding activity is reduced, and E2F4 is primarily nuclear. E2F4-p130 becomes the predominant E2F-pocket complex formed on E2F sites, but, unlike the complex that typifies resting cells, cyclin A and CDK2 are also present. Administration of dexamethasone at this, but not earlier stages, results in reduction of cyclin A and CDK2 levels with a parallel decrease in the associated kinase activity, dissociation of cyclin A-CDK2 from the E2F4-p130 complexes, and inhibition of G1/S transition. The glucocorticoid-mediated cell cycle attenuation is also accompanied by, but not attributable to, increased p27(kip1) and decreased p21(waf1/cip1) levels. The attenuation of osteoblast growth to high density by dexamethasone is associated with severe impairment of mineralized extracellular matrix formation, unless treatment commences in cultures that have already grown to high density. Both the antimitotic and the antiphenotypic effects are reversible, and both are antagonized by RU486. Thus, glucocorticoids induce premature attenuation of the osteoblast cell cycle, possibly contributing to the osteoporosis induced by these drugs in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0034733664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034733664&partnerID=8YFLogxK

U2 - 10.1074/jbc.M001758200

DO - 10.1074/jbc.M001758200

M3 - Article

C2 - 10867026

AN - SCOPUS:0034733664

VL - 275

SP - 19992

EP - 20001

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 26

ER -